Analyst ratings, especially from reputable firms like Baird, can significantly influence investor sentiment and stock prices. An Outperform rating suggests that Baird expects Coherus BioSciences to perform better than the market or its sector, which could lead to increased investor interest and a potential rise in the stock price in the short term.